Stock

Shilpa Medicare — MTF Book

SHILPAMED · Shilpa Medicare Limited
Health Technology

Daily Margin Trading Facility book for Shilpa Medicare across NSE and BSE, from 01 Aug 2017. All figures in ₹ crore, derived from exchange public disclosures.

What is Shilpa Medicare’s MTF book?

Shilpa Medicare Limited (SHILPAMED) has ₹106 crore funded under Margin Trading Facility across NSE and BSE as of 23 Oct 2026 — 0.07% of India’s MTF book, ranking #360. Over 1M (the last 30 trading days) the funded value has fallen 22.2%, with the number of shares under margin down 23.2%.

Funded value
₹106 Cr
as of 23 Oct 2026
Rank in book
#360
2,072 days tracked
Share of book
0.07%
of the whole NSE + BSE book
Peak funded
₹170 Cr
on 01 Sep 2026
Largest single-day addition
+₹36 Cr
on 05 Jun 2024
Largest single-day unwind
−₹34 Cr
on 01 Dec 2021
Free-float market cap
₹10,120 Cr
full market cap ₹16,904 Cr · 59.9% free float · Small cap
MTF share of free float
1.44%
0.7× the median small cap · 1.7× the Health Technology median

Share of free float on margin, month by month

Shares under margin at each month-end as a share of free-float shares, using that month-end’s share count and the free-float filing public at the time. It counts shares, not value, so a price move does not move it by itself.

0.00%1.69%3.39%5.08%Feb 2024Oct 2026
View as table: share of free float on margin29 months
Month-end% of free float
23 Oct 20261.443%
30 Sep 20261.744%
31 Aug 20262.156%
31 Jul 20261.734%
30 Jun 20262.011%
29 May 20261.896%
30 Apr 20261.296%
30 Mar 20261.018%
11 Feb 2026†0.357%
26 Dec 2025†0.360%
28 Nov 20250.372%
01 Jul 2025†0.213%
30 Jun 20250.319%
30 May 20251.786%
30 Apr 20251.403%
28 Mar 20251.382%
28 Feb 20251.601%
31 Jan 20252.032%
31 Dec 20242.168%
29 Nov 20242.440%
31 Oct 20243.108%
30 Sep 20243.214%
30 Aug 20242.839%
31 Jul 20243.312%
28 Jun 20244.444%
31 May 20243.482%
30 Apr 20243.948%
28 Mar 20243.365%
29 Feb 20244.174%

† Not the month’s last trading day: the last day the stock was in the archive that month (before 11 Nov 2025 the archive kept only the 500 largest positions).

Dated events

NSE & BSE split

How SHILPAMED’s funded book divides across the two exchanges, as of 23 Oct 2026.
NSE
NSE ₹104 Cr · 98.4%BSE ₹2 Cr · 1.6%

MTF vs Price

Margin-funded outstanding for SHILPAMED in ₹ crore against the closing price, adjusted for splits and bonuses. Each window uses the same reference date as the table below, so the two agree. Funded value moves with the price on its own, so the line under the chart reads the share count instead — that is what shows whether more stock is genuinely being borrowed against.
MTF book (₹ Cr)

Price and liquidity

Adjusted for splits and bonuses, so a change across a corporate action reflects the market rather than the share count.
Last close
₹864.30
as of 23 Oct 2026
Price, 1M
−10.0%
adjusted for splits and bonuses
Delivery, 20-day avg
44.6%
of traded volume actually settled
Sessions to unwind
4
of average deliverable volume
Shares under margin divided by average daily deliverable volume over the last 20 sessions.

Book, shares and price by window

Funded value moves with the price on its own, so the share count is what shows whether more stock is actually being borrowed against. The last column reads the two together.
WindowBook ΔBook %SharesPriceReading
1D+₹0+0.2%−0.1%
−1,729
+0.4%unwinding into strength
10D−₹21−16.7%−14.4%
−2,85,143
−15.7%unwinding as it falls
1M−₹30−22.2%−23.2%
−5,10,623
−10.0%unwinding as it falls
3M+₹7+6.7%−18.2%
−3,76,504
+43.2%unwinding into strength
6M+₹50+88.8%+9.5%
+1,46,564
+102.1%building into strength
1Ynot enough history

Shares under margin

Number of shares funded via MTF over time (NSE + BSE combined).

Rank trajectory

Where SHILPAMED has sat in the funded-value ranking each day (1 = most funded). Lower is more prominent.

SHILPAMED — last 30 trading days

Combined NSE + BSE funded value, day-on-day change, share of the whole book, and rank. Newest first.
DateCombined (₹ Cr)Day Δ (₹ Cr)% of bookRank
23 Oct 2026106+₹00.07%360
22 Oct 2026106+₹20.07%363
21 Oct 2026104−₹20.07%371
19 Oct 2026105−₹100.07%372
16 Oct 2026115−₹20.07%344
15 Oct 2026117−₹30.07%334
14 Oct 2026120−₹30.08%325
13 Oct 2026123−₹40.08%315
12 Oct 2026126+₹00.08%305
09 Oct 2026126−₹10.08%304
08 Oct 2026127−₹00.08%302
07 Oct 2026127−₹10.08%302
06 Oct 2026128−₹20.08%301
05 Oct 2026130+₹00.08%297
01 Oct 2026129−₹10.08%299
30 Sep 2026131−₹00.08%299
29 Sep 2026131+₹10.08%298
28 Sep 2026130−₹10.08%302
25 Sep 2026131−₹10.08%303
24 Sep 2026132+₹10.08%301
23 Sep 2026131+₹10.08%303
22 Sep 2026130+₹10.08%302
21 Sep 2026129−₹10.08%302
18 Sep 2026130−₹10.09%293
17 Sep 2026131−₹20.09%294
16 Sep 2026134−₹50.09%289
15 Sep 2026139+₹10.09%282
11 Sep 2026138−₹30.09%286
10 Sep 2026140+₹00.09%277
09 Sep 2026140—0.09%273

SHILPAMED within Health Technology

Ranked #17 of 61 funded Health Technology stocks, carrying 1.6% of that sector’s margin book. Its 1.44% of free float on margin is 1.6× the sector median of 0.90%. Nearest names by funded value:
#StockMTF book (₹ Cr)% of sector% of free floatBook, 1M
15BIOCONBiocon Limited₹1221.8%0.34%+10.2%
16PPLPHARMAPiramal Pharma₹1111.7%0.64%+5.8%
17SHILPAMEDShilpa Medicare₹1061.6%1.44%−22.2%
18DRREDDYDr. Reddy's Laboratories₹911.3%0.12%−46.8%
19AARTIPHARMAarti Pharmalabs₹871.3%1.84%+41.9%

All Health Technology stocks and how the sector has moved →

Disclaimer. Data sourced from daily margin trading disclosure provided by NSE and BSE. This website and page are meant for educational and information only — not investment advice. MTF is leveraged and can amplify losses. Rules, margins, rates and eligible-stock lists change; verify current details with your broker and SEBI/exchange circulars. IndiaMTF.com is not a SEBI-registered intermediary, broker, or investment adviser and has no affiliation with SEBI, NSE or BSE. Figures are reproduced from publicly disclosed exchange data, may be delayed or revised, and should be independently verified before any trading decision. Consult a SEBI-registered investment adviser before investing.